Substance / Medication

Lodoxamide

Overview

Active Ingredient
lodoxamide
RxNorm CUI
52151

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35
Kim Mi-Jeong, Park Soo-Jin, Nam So-Yeon et al. · Biomol Ther (Seoul) · 2020
PMID: 31189299OtherFull text (PMC)
Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
Rodriguez-Garcia Alejandro, Macias-Rodriguez Yolanda, Gonzalez-Gonzalez Jose M · Int Ophthalmol · 2018
PMID: 28602013Other
Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
Das Dial, Khan Moosa, Gul Ali et al. · J Pak Med Assoc · 2011
PMID: 21465936Other
Protective effect of lodoxamide on hepatic steatosis through GPR35.
Nam So-Yeon, Park Soo-Jin, Im Dong-Soon · Cell Signal · 2019
PMID: 30304698Preclinical
The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.
MacKenzie Amanda E, Caltabiano Gianluigi, Kent Toby C et al. · Mol Pharmacol · 2014
PMID: 24113750PreclinicalFull text (PMC)
[Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
Dekaris Iva, Gabrić Nikica, Lazić Ratimir et al. · Acta Med Croatica · 2002
PMID: 12630339Trial
Lodoxamide as adjuvant therapy in patients with dry eye.
Petricek I, Pokupec R, Petricek G et al. · Coll Antropol · 2001
PMID: 11817007Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lodoxamide (substance)
SNOMED CT
372552005
UMLS CUI
C0126120
RxNorm CUI
52151

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.